A. Gudgeon

Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate.

P Dombernowsky, I E Smith, Geoffrey Falkson et al. · Journal of Clinical Oncology · 1998 · 640 citations

Burdens and Benefits of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil and Tamoxifen for Elderly Patients With Breast Cancer: The International Breast Cancer Study Group Trial VII

Diana Crivellari, Marco Bonetti, Monica Castiglione‐Gertsch et al. · Journal of Clinical Oncology · 2000 · 294 citations

Effect of Pregnancy on Overall Survival After the Diagnosis of Early-Stage Breast Cancer

Shari Gelber, Alan S. Coates, Aron Goldhirsch et al. · Journal of Clinical Oncology · 2001 · 210 citations

Identifying Breast Cancer Patients at High Risk for Bone Metastases

Marco Colleoni, Anne O’Neill, Aron Goldhirsch et al. · Journal of Clinical Oncology · 2000 · 125 citations

Risk of Breast Cancer in Relation to the Use of Injectable Progestogen Contraceptives and Combined Estrogen/Progestogen Contraceptives

S. Shapiro, Lynn Rosenberg, M. Timm Hoffman et al. · American Journal of Epidemiology · 2000 · 105 citations

Contraceptive Use, Breast Oncology, Hormonal Contraceptive +18